Cargando…

Hyaluronic Acid-Targeted Stimuli-Sensitive Nanomicelles Co-Encapsulating Paclitaxel and Ritonavir to Overcome Multi-Drug Resistance in Metastatic Breast Cancer and Triple-Negative Breast Cancer Cells

Active targeting and overcoming multi-drug resistance (MDR) can be some of the important attributes of targeted therapy for metastatic breast cancer (MBC) and triple-negative breast cancer (TNBC) treatment. In this study, we constructed a hyaluronic acid (HA)-decorated mixed nanomicelles-encapsulati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gote, Vrinda, Sharma, Amar Deep, Pal, Dhananjay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865449/ https://www.ncbi.nlm.nih.gov/pubmed/33513992 http://dx.doi.org/10.3390/ijms22031257

Ejemplares similares

Self-Assembling Tacrolimus Nanomicelles for Retinal Drug Delivery
por: Gote, Vrinda, et al.
Publicado: (2020)

Octreotide-Targeted Lcn2 siRNA PEGylated Liposomes as a Treatment for Metastatic Breast Cancer
por: Gote, Vrinda, et al.
Publicado: (2021)

Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue
por: Gote, Vrinda, et al.
Publicado: (2021)

Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration
por: Dian, Ling-Hui, et al.
Publicado: (2018)

Self-assembled and pH-responsive polymeric nanomicelles impart effective delivery of paclitaxel to cancer cells
por: Jangid, Ashok Kumar, et al.
Publicado: (2021)

Penfluridol overcomes paclitaxel resistance in metastatic breast cancer
por: Gupta, Nehal, et al.
Publicado: (2019)

BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers
por: Blanchard, Zannel, et al.
Publicado: (2015)

pH-activated, mitochondria-targeted, and redox-responsive delivery of paclitaxel nanomicelles to overcome drug resistance and suppress metastasis in lung cancer
por: Wang, He, et al.
Publicado: (2021)

Dual functionalized hyaluronic acid micelles loading paclitaxel for the therapy of breast cancer
por: Liu, Zhanbiao, et al.
Publicado: (2023)

BioPerine Encapsulated Nanoformulation for Overcoming Drug-Resistant Breast Cancers
por: Pillai, Sindhu C, et al.
Publicado: (2020)

Reduction-Sensitive Dual Functional Nanomicelles for Improved Delivery of Paclitaxel
por: Zhang, Xiaolan, et al.
Publicado: (2014)

Hyaluronic Acid-Functionalized Nanomicelles Enhance SAHA Efficacy in 3D Endometrial Cancer Models
por: Edwards, Kadie, et al.
Publicado: (2021)

Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells
por: Zhou, Yi, et al.
Publicado: (2017)

Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance
por: Wang, Shuanghu, et al.
Publicado: (2017)

Curcumin-Encapsulated Nanomicelles Improve Cellular Uptake and Cytotoxicity in Cisplatin-Resistant Human Oral Cancer Cells
por: Kumbar, Vijay M., et al.
Publicado: (2022)

Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats
por: Li, Wenhao, et al.
Publicado: (2020)

Tumor Microenvironment Responsive Nanomicelle with Folic Acid Modification Co-Delivery of Doxorubicin/Shikonin for Triple Negative Breast Cancer Treatment
por: Zhong, Wu, et al.
Publicado: (2023)

Effects of retinoid-loaded hyaluronic acid nanomicelles on vaginal epithelium in a murine menopause model
por: Kim, Taehee, et al.
Publicado: (2023)

Anti-tumor activity of nanomicelles encapsulating CXCR4 peptide antagonist E5
por: Fang, Xiaocui, et al.
Publicado: (2017)

Co-encapsulation of paclitaxel and 5-fluorouracil in folic acid-modified, lipid-encapsulated hollow mesoporous silica nanoparticles for synergistic breast cancer treatment
por: Yin, Huanli, et al.
Publicado: (2022)

Self-Assembled Nanomicelles of Affibody-Drug Conjugate with Excellent Therapeutic Property to Cure Ovary and Breast Cancers
por: Xia, Xuelin, et al.
Publicado: (2021)

Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy
por: Yang, Qianmei, et al.
Publicado: (2020)

Morphine counteracts the effects of paclitaxel in triple-negative breast cancer cells
por: Sezer, Gülay, et al.
Publicado: (2022)

A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy
por: Liu, Yuetong, et al.
Publicado: (2023)

Preparation, Characterization, and Inhibition of Hyaluronic Acid Oligosaccharides in Triple-Negative Breast Cancer
por: Han, Wenwei, et al.
Publicado: (2019)

α(1)-Acid Glycoprotein-Decorated Hyaluronic Acid Nanoparticles for Suppressing Metastasis and Overcoming Drug Resistance Breast Cancer
por: Omar, Haneen, et al.
Publicado: (2022)

Stimuli-Responsive Nanomedicines for Overcoming Cancer Multidrug Resistance
por: Zhou, Lei, et al.
Publicado: (2018)

Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo
por: Meng, Jie, et al.
Publicado: (2016)

Obatoclax and Paclitaxel Synergistically Induce Apoptosis and Overcome Paclitaxel Resistance in Urothelial Cancer Cells
por: Jiménez-Guerrero, Rocío, et al.
Publicado: (2018)

Research advances and new challenges in overcoming triple-negative breast cancer
por: Zong, Yu, et al.
Publicado: (2021)

Methylseleninic Acid Enhances Paclitaxel Efficacy for the Treatment of Triple-Negative Breast Cancer
por: Qi, Yanfeng, et al.
Publicado: (2012)

Encapsulated Phytomedicines against Cancer: Overcoming the “Valley of Death”
por: Brotons-Canto, Ana, et al.
Publicado: (2023)

Resistance and Overcoming Resistance in Breast Cancer
por: Luque-Bolivar, Andrea, et al.
Publicado: (2020)

Design of an L-Valine-Modified Nanomicelle-Based Drug Delivery System for Overcoming Ocular Surface Barriers
por: Wu, Huimin, et al.
Publicado: (2022)

(99m)Tc-Radiolabeled TPGS Nanomicelles Outperform (99m)Tc-Sestamibi as Breast Cancer Imaging Agent
por: Tesan, Fiorella C., et al.
Publicado: (2019)

nab-Paclitaxel dose and schedule in breast cancer
por: Martín, Miguel
Publicado: (2015)

Neoadjuvant nab-paclitaxel in the treatment of breast cancer
por: Ueno, Naoto T., et al.
Publicado: (2016)

Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer
por: Abu Samaan, Tala M., et al.
Publicado: (2019)

S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer
por: Hou, Zhenyan, et al.
Publicado: (2023)

A multi-functional hypoxia/esterase dual stimulus responsive and hyaluronic acid-based nanomicelle for targeting delivery of chloroethylnitrosouea
por: Li, Duo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_brm12l5h8md78gue7bgii08fra